What Is TRT and Who Needs It
Testosterone replacement therapy (TRT) is a medically supervised treatment for men with clinically low testosterone, a condition known as hypogonadism. Symptoms include persistent fatigue, reduced libido, erectile dysfunction, loss of muscle mass, increased body fat, mood changes, and difficulty concentrating. A diagnosis requires both symptoms and confirmed low testosterone levels on blood work — typically two morning total testosterone readings below 300 ng/dL.
An estimated 4 to 5 million American men have hypogonadism, but only about 5% receive treatment. Telehealth is changing that equation by making it easier to get tested, diagnosed, and treated without multiple in-person visits to a urologist or endocrinologist.
How Online TRT Works
The online TRT process begins with a comprehensive lab panel. Most telehealth TRT providers require blood work before your first consultation. Some send at-home lab kits; others use national lab networks where you walk in for a blood draw. The panel typically includes total testosterone, free testosterone, estradiol, SHBG, PSA, CBC, and a metabolic panel.
After reviewing your results and medical history during a video consultation, the provider determines whether you are a candidate for TRT. If prescribed, treatment options include injectable testosterone cypionate (the most common), topical gels or creams, or in some cases pellet therapy. Most patients self-administer injections at home once or twice weekly. The provider schedules follow-up labs at six to eight weeks to assess your response and adjust dosing, then moves to quarterly monitoring once levels are optimized.
Lab Requirements and Monitoring
Responsible TRT management requires regular lab monitoring. Expect blood work every six to eight weeks during the initial optimization phase and every three to six months once stable. Key markers your provider will track include total and free testosterone, hematocrit (TRT can increase red blood cell production), estradiol, PSA for prostate screening, and lipid panels.
Any legitimate telehealth TRT provider will require labs before prescribing and insist on regular follow-up testing. Be cautious of platforms that offer testosterone without proper lab work — this is a red flag for substandard care. Good monitoring is what separates medically supervised TRT from unregulated hormone use.
Cost and Insurance for Online TRT
Online TRT costs vary widely. Monthly fees at telehealth TRT clinics typically range from $100 to $300 and may or may not include the medication itself. Injectable testosterone cypionate is relatively inexpensive (often $30 to $80 per month for the medication alone), while gels and creams cost more. Lab work is sometimes included in subscription pricing or billed separately at $100 to $300 per panel.
Some telehealth TRT providers accept insurance, while many operate on a cash-pay model. If using insurance, note that testosterone is a controlled substance (Schedule III) and may require prior authorization. Compare total cost including consultations, labs, and medication when evaluating platforms.
Choosing an Online TRT Provider
When selecting a telehealth TRT provider, evaluate their clinical rigor first. Look for providers who require comprehensive baseline labs, have clear monitoring protocols, and employ board-certified clinicians with experience in hormone management. Other important factors include state availability, medication delivery options, responsiveness between appointments, and whether they offer ancillary treatments such as HCG (for fertility preservation) or estrogen blockers.
Avoid platforms that promise specific testosterone levels or guarantee results — individual responses to TRT vary significantly, and any responsible provider will set realistic expectations. Explore the men's health and hormone therapy providers listed below to compare your options.
TRT vs. HRT: Understanding the Difference
The terms TRT and HRT are often used interchangeably but refer to different treatment approaches. Testosterone replacement therapy (TRT) refers specifically to testosterone supplementation in men to treat hypogonadism. Hormone replacement therapy (HRT) is a broader term used most commonly in women's health to describe estrogen and progesterone supplementation during perimenopause and menopause.
Men's HRT and TRT are functionally the same thing. Both describe testosterone treatment. The distinction matters because some telehealth platforms market themselves as "men's HRT" to signal a broader wellness approach (covering not just testosterone but also thyroid, DHEA, and other hormones), while others use "TRT" to signal clinical focus specifically on testosterone optimization.
Women's HRT is an entirely different treatment landscape, involving estrogen (estradiol), progesterone, and sometimes low-dose testosterone. The diagnostic criteria, monitoring markers, risk considerations, and treatment protocols for women's HRT are substantially different from men's TRT. Providers who specialize in one do not automatically have expertise in the other. If you are a woman seeking hormone therapy, look for providers who specialize in menopause and women's hormonal health rather than general "hormone therapy" platforms that may be primarily TRT-focused.
Symptoms That Warrant TRT Evaluation
Not every man with low energy or reduced libido has hypogonadism, and telehealth TRT platforms vary significantly in how carefully they distinguish clinical low testosterone from lifestyle factors. The following symptoms, when persistent and not explained by other conditions, warrant getting a testosterone panel:
Fatigue and reduced energy that does not improve with adequate sleep, reduced libido or sexual desire, erectile dysfunction or difficulty maintaining erections, loss of muscle mass despite consistent training, increased body fat particularly in the abdominal region, mood changes including depression and irritability, difficulty concentrating or brain fog, reduced bone density identified on a DEXA scan, and reduced body or facial hair growth.
A diagnosis of hypogonadism requires both symptoms AND confirmed low testosterone on blood work -- specifically two morning fasting total testosterone readings below 300 ng/dL. Testing only once, or testing at the wrong time of day (testosterone is highest in the morning), can produce misleading results. Secondary hypogonadism (a pituitary or hypothalamic problem) requires additional workup including LH and FSH. Most telehealth TRT platforms evaluate primary hypogonadism; refer cases with pituitary concerns to in-person endocrinology.
What to Expect Month-by-Month on TRT
Testosterone therapy produces changes over different timescales. Understanding the timeline helps set realistic expectations and avoid discontinuing treatment prematurely.
Weeks 1 to 4: Many men report improved mood and energy within the first two to four weeks, as testosterone levels begin rising from baseline. Sleep quality often improves early. Libido may increase. Physical changes (muscle mass, body composition) are not yet visible.
Weeks 4 to 8: Your provider will order the first follow-up labs approximately six to eight weeks into therapy. This panel checks total and free testosterone, estradiol, hematocrit, and PSA. If levels are not in the optimal range, your provider will adjust your dose. Most men reach therapeutic levels within this window.
Months 2 to 3: Sexual function improvements typically appear within six to twelve weeks. Erection quality and frequency often improve noticeably by the end of the third month. Body fat may begin shifting.
Months 3 to 6: Body composition changes become visible. Lean muscle mass increases, particularly with resistance training. Motivation and confidence are often reported as improved. Some men experience acne during this phase as androgens increase.
Months 6 to 12: Full body composition changes are typically apparent. Bone density improvements are measurable on DEXA scan after about 12 months. Ongoing quarterly monitoring establishes your stable maintenance dose.
Long-term: Well-managed TRT can be maintained indefinitely with regular monitoring. The primary long-term considerations are hematocrit management (donation or phlebotomy if it rises above 54%), annual PSA surveillance, and fertility preservation if relevant.
Federal Regulations and Telehealth Prescribing Rules
Testosterone is classified as a Schedule III controlled substance under the Controlled Substances Act, the same category as anabolic steroids. This has meaningful implications for telehealth prescribing.
Before the COVID-19 pandemic, the Ryan Haight Online Pharmacy Consumer Protection Act (2008) required an in-person examination before any controlled substance could be prescribed via telemedicine. DEA emergency waivers during the pandemic allowed telehealth providers to prescribe controlled substances including testosterone without an initial in-person visit. These emergency authorities were extended multiple times after the public health emergency ended.
As of 2026, the DEA has implemented new rules for telehealth prescribing of controlled substances. Telehealth providers can prescribe Schedule III substances like testosterone after a video evaluation meeting clinical criteria, provided the provider is registered in the patient's state and maintains proper documentation. The prescribing provider must be a licensed practitioner in the state where the patient is located.
State-specific rules add another layer. A small number of states have additional requirements for testosterone prescribing beyond federal rules. Most states permit telehealth TRT prescribing after a proper clinical evaluation. Platforms operating in all 50 states have legal departments that ensure compliance with each state's specific rules.
What this means practically: you will need a video consultation with a licensed provider before receiving your first testosterone prescription via telehealth. Platforms that offer testosterone prescriptions without any clinical evaluation are operating outside legal requirements and should be avoided.